What is Genotox Laboratories?
Genotox Laboratories, based in Austin, Texas, is a CLIA-certified entity specializing in advanced toxicology and pharmacogenetic testing. The company offers DNA-verified urine drug tests and comprehensive pharmacogenetic assessments, utilizing its innovative ToxProtect system for accurate sample authentication. This technology is crucial in preventing opioid addiction and monitoring patient compliance, thereby enabling healthcare providers to develop personalized medication programs based on individual genetic profiles. Their commitment to patient-centric care is reflected in their delivery of reliable lab results.
How much funding has Genotox Laboratories raised?
Genotox Laboratories has raised a total of $2M across 2 funding rounds:
Debt
$1M
Debt
$1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1M led by PPP
Key Investors in Genotox Laboratories
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Genotox Laboratories?
The recent major strategic investment positions Genotox Laboratories for significant expansion in the pharmacogenetic and toxicology testing market. This enterprise-level funding is expected to fuel advancements in their ToxProtect system and broaden their reach to more healthcare providers. The company's focus on data-driven patient care and compliance monitoring aligns with growing industry trends, suggesting a trajectory towards becoming a leader in personalized medicine solutions. Future growth will likely involve scaling operations, enhancing technological capabilities, and potentially exploring new diagnostic applications.
See full Genotox Laboratories company page
